Scarica l'app Stockscreener
3.71
0.00%
0.00
Precedente Chiudi:
$3.71
Aprire:
$3.75
Volume 24 ore:
7.07M
Relative Volume:
1.21
Capitalizzazione di mercato:
$1.27B
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-10.60
EPS:
-0.35
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
+15.94%
1M Prestazione:
+17.78%
6M Prestazione:
+123.49%
1 anno Prestazione:
+58.55%
Intervallo 1D:
$3.665
$3.85
Intervallo di 1 settimana:
$3.15
$3.95
Portata 52W:
$1.54
$4.0899
Nuvation Bio Inc Stock (NUVB) Company Profile
Nome
Nuvation Bio Inc
Settore
Industria
Telefono
(415) 754-3517
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Confronta NUVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
3.71 | 1.27B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.30 | 104.83B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.35 | 60.43B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
800.00 | 48.45B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
343.87 | 37.91B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Jefferies | Buy |
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-02 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2021-03-08 | Iniziato | BTIG Research | Buy |
| 2021-03-08 | Iniziato | Cowen | Outperform |
| 2021-03-08 | Iniziato | Jefferies | Buy |
| 2021-03-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
Is Nuvation Bio Inc. Warrants stock undervalued after correctionMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com
Can Nuvation Bio Inc. Class stock resist broad market declinesMarket Activity Report & Safe Entry Momentum Tips - newser.com
Is Nuvation Bio Inc. stock resilient to inflationWeekly Stock Report & Fast Gaining Stock Reports - newser.com
Will Nuvation Bio Inc. Class stock top growth indexesBond Market & Capital Efficient Trading Techniques - newser.com
Is Nuvation Bio Inc. reversing from oversold territoryJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com
Will Nuvation Bio Inc. Warrants stock sustain uptrend momentumMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Custom watchlist performance reports with Nuvation Bio Inc.Earnings Growth Summary & Stepwise Swing Trade Plans - newser.com
How big funds are accumulating Nuvation Bio Inc. Warrants stockGlobal Markets & Technical Buy Zone Confirmations - newser.com
Nuvation Bio Inc. stock retracement – recovery analysis2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
How Nuvation Bio Inc. Class stock moves in volatile trading sessionsOptions Play & Real-Time Volume Trigger Notifications - newser.com
Will Nuvation Bio Inc. stock continue dividend increasesMarket Growth Review & Low Drawdown Investment Ideas - newser.com
How moving averages guide Nuvation Bio Inc. tradingMarket Growth Summary & Free Fast Gain Swing Trade Alerts - newser.com
Assessing Nuvation Bio (NUVB) Valuation After Recent Share Price Momentum in the Biotech Sector - Yahoo
Nuvation Bio Hits Day High with 15.63% Surge in Strong Intraday Performance - Markets Mojo
Multi factor analysis applied to Nuvation Bio Inc.Market Movers & Accurate Intraday Trade Tips - newser.com
Nuvation Bio (NUVB)’s Taletrectinib Selected as Preferred Agent for Cancer Treatment - MSN
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer - Investing News Network
Jefferies initiates Nuvation Bio stock with Buy rating, $10 price target - Investing.com Nigeria
Why Nuvation Bio Stock Is Skyrocketing Today - Mitrade
Nuvation Bio Shares Rise After First Patient Enrolled in Phase 3 Lung Cancer Drug Trial - MarketScreener
Nuvation issues trial update as Jefferies says buy (NUVB) - Seeking Alpha
United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday - Benzinga
Jefferies Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq
Nuvation Bio enrolls first patient in phase 3 lung cancer trial - Investing.com
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer - Business Wire
What market sentiment indicators show for Nuvation Bio Inc. Class stockProduct Launch & Low Risk Investment Opportunities - newser.com
3 Of My Favorite Biotech Stocks Under $10 - Seeking Alpha
Will breakout in Nuvation Bio Inc. lead to full recoveryMarket Weekly Review & Verified Entry Point Signals - newser.com
Why Nuvation Bio Inc. stock is popular among millennials2025 Valuation Update & High Accuracy Trade Alerts - newser.com
Nuvation Bio Surges on Japanese Approval of Ibtrozi for Lung Cancer - StocksToTrade
Nuvation Bio (NUVB) Surges Amid Major Regulatory Milestone in Japan - timothysykes.com
What analysts say about Nuvation Bio Inc stockMorning Star Patterns & Discover Strategies with Fellow Traders - earlytimes.in
Nuvation Bio Soars As Japan Approves Ibtrozi for Advanced Lung Cancer - StocksToTrade
Nuvation Bio Stock Hits Day Low of $3.00 Amid Price Pressure - Markets Mojo
Nuvation Bio (NYSE:NUVB) Stock Price Up 7.2%Here's Why - MarketBeat
Nuvation Bio Inc Azioni (NUVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.68%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):